Wells Fargo & Company Novo Nordisk A S Call Options Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 10, 2024
SELL
$102.11 - $135.92 $1.33 Million - $1.77 Million
-13,000 Reduced 34.21%
25,000 $3.21 Million
Q4 2023

Feb 09, 2024
SELL
$87.78 - $105.45 $158,004 - $189,810
-1,800 Reduced 4.52%
38,000 $3.93 Million
Q3 2023

Nov 13, 2023
BUY
$90.94 - $199.54 $3.62 Million - $7.94 Million
39,800 New
39,800 $3.62 Million
Q1 2020

May 14, 2020
BUY
$49.46 - $64.78 $1.44 Million - $1.89 Million
29,100 New
29,100 $113,000

Others Institutions Holding NVO

# of Institutions
1,959
Shares Held
321M
Call Options Held
5.16M
Put Options Held
4.96M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $249B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email